COVID-19 Impact on Influenza Vaccines Market, Global Research Reports 2020-2021


This report covers market size and forecasts of Influenza Vaccines, including the following market information:
    Global Influenza Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Influenza Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Influenza Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
    Global Influenza Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players
Major competitors identified in this market include AstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, Visterra, etc.

Based on the Region:
    Asia-Pacific (China, Japan, South Korea, India and ASEAN)
    North America (US and Canada)
    Europe (Germany, France, UK and Italy)
    Rest of World (Latin America, Middle East & Africa)

Based on the Type:
    Trivalent Flu Vaccines
    Quadrivalent Flu Vaccines

Based on the Application:
    Adults
    Pediatrics
1.1 Research Scope
    1.2 Market Segmentation
    1.3 Research Objectives
    1.4 Research Methodology
        1.4.1 Research Process
        1.4.2 Data Triangulation
        1.4.3 Research Approach
        1.4.4 Base Year
    1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
        1.5.2 Covid-19 Impact: Commodity Prices Indices
        1.5.3 Covid-19 Impact: Global Major Government Policy
    1.6 The Covid-19 Impact on Influenza Vaccines Industry
    1.7 COVID-19 Impact: Influenza Vaccines Market Trends

2 Global Influenza Vaccines Quarterly Market Size Analysis
    2.1 Influenza Vaccines Business Impact Assessment - COVID-19
        2.1.1 Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
        2.1.2 Global Influenza Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    2.2 Global Influenza Vaccines Quarterly Market Size 2020-2021
    2.3 COVID-19-Driven Market Dynamics and Factor Analysis
        2.3.1 Drivers
        2.3.2 Restraints
        2.3.3 Opportunities
        2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
    3.1 Global Influenza Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    3.2 Global Influenza Vaccines Factory Price by Manufacturers
    3.3 Location of Key Manufacturers Influenza Vaccines Manufacturing Factories and Area Served
    3.4 Date of Key Manufacturers Enter into Influenza Vaccines Market
    3.5 Key Manufacturers Influenza Vaccines Product Offered
    3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Influenza Vaccines Segments, By Type
    4.1 Introduction
        1.4.1 Trivalent Flu Vaccines
        1.4.2 Quadrivalent Flu Vaccines
    4.2 By Type, Global Influenza Vaccines Market Size, 2019-2021
        4.2.1 By Type, Global Influenza Vaccines Market Size by Type, 2020-2021
        4.2.2 By Type, Global Influenza Vaccines Price, 2020-2021

5 Impact of Covid-19 on Influenza Vaccines Segments, By Application
    5.1 Overview
        5.5.1 Adults
        5.5.2 Pediatrics
    5.2 By Application, Global Influenza Vaccines Market Size, 2019-2021
        5.2.1 By Application, Global Influenza Vaccines Market Size by Application, 2019-2021
        5.2.2 By Application, Global Influenza Vaccines Price, 2020-2021

6 Geographic Analysis
    6.1 Introduction
    6.2 North America
        6.2.1 Macroeconomic Indicators of US
        6.2.2 US
        6.2.3 Canada
    6.3 Europe
        6.3.1 Macroeconomic Indicators of Europe
        6.3.2 Germany
        6.3.3 France
        6.3.4 UK
        6.3.5 Italy
    6.4 Asia-Pacific
        6.4.1 Macroeconomic Indicators of Asia-Pacific
        6.4.2 China
        6.4.3 Japan
        6.4.4 South Korea
        6.4.5 India
        6.4.6 ASEAN
    6.5 Rest of World
        6.5.1 Latin America
        6.5.2 Middle East and Africa

7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Business Overview
        7.1.2 AstraZeneca Influenza Vaccines Quarterly Production and Revenue, 2020
        7.1.3 AstraZeneca Influenza Vaccines Product Introduction
        7.1.4 AstraZeneca Response to COVID-19 and Related Developments
    7.2 CSL
        7.2.1 CSL Business Overview
        7.2.2 CSL Influenza Vaccines Quarterly Production and Revenue, 2020
        7.2.3 CSL Influenza Vaccines Product Introduction
        7.2.4 CSL Response to COVID-19 and Related Developments
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Business Overview
        7.3.2 GlaxoSmithKline Influenza Vaccines Quarterly Production and Revenue, 2020
        7.3.3 GlaxoSmithKline Influenza Vaccines Product Introduction
        7.3.4 GlaxoSmithKline Response to COVID-19 and Related Developments
    7.4 Sanofi
        7.4.1 Sanofi Business Overview
        7.4.2 Sanofi Influenza Vaccines Quarterly Production and Revenue, 2020
        7.4.3 Sanofi Influenza Vaccines Product Introduction
        7.4.4 Sanofi Response to COVID-19 and Related Developments
    7.5 Altimmune
        7.5.1 Altimmune Business Overview
        7.5.2 Altimmune Influenza Vaccines Quarterly Production and Revenue, 2020
        7.5.3 Altimmune Influenza Vaccines Product Introduction
        7.5.4 Altimmune Response to COVID-19 and Related Developments
    7.6 BionVax
        7.6.1 BionVax Business Overview
        7.6.2 BionVax Influenza Vaccines Quarterly Production and Revenue, 2020
        7.6.3 BionVax Influenza Vaccines Product Introduction
        7.6.4 BionVax Response to COVID-19 and Related Developments
    7.7 FluGen
        7.7.1 FluGen Business Overview
        7.7.2 FluGen Influenza Vaccines Quarterly Production and Revenue, 2020
        7.7.3 FluGen Influenza Vaccines Product Introduction
        7.7.4 FluGen Response to COVID-19 and Related Developments
    7.8 FOLIA BIOTECH
        7.8.1 FOLIA BIOTECH Business Overview
        7.8.2 FOLIA BIOTECH Influenza Vaccines Quarterly Production and Revenue, 2020
        7.8.3 FOLIA BIOTECH Influenza Vaccines Product Introduction
        7.8.4 FOLIA BIOTECH Response to COVID-19 and Related Developments
    7.9 Genentech
        7.9.1 Genentech Business Overview
        7.9.2 Genentech Influenza Vaccines Quarterly Production and Revenue, 2020
        7.9.3 Genentech Influenza Vaccines Product Introduction
        7.9.4 Genentech Response to COVID-19 and Related Developments
    7.10 Green Cross
        7.10.1 Green Cross Business Overview
        7.10.2 Green Cross Influenza Vaccines Quarterly Production and Revenue, 2020
        7.10.3 Green Cross Influenza Vaccines Product Introduction
        7.10.4 Green Cross Response to COVID-19 and Related Developments
    7.11 Medicago
        7.11.1 Medicago Business Overview
        7.11.2 Medicago Influenza Vaccines Quarterly Production and Revenue, 2020
        7.11.3 Medicago Influenza Vaccines Product Introduction
        7.11.4 Medicago Response to COVID-19 and Related Developments
    7.12 Moderna Therapeutics
        7.12.1 Moderna Therapeutics Business Overview
        7.12.2 Moderna Therapeutics Influenza Vaccines Quarterly Production and Revenue, 2020
        7.12.3 Moderna Therapeutics Influenza Vaccines Product Introduction
        7.12.4 Moderna Therapeutics Response to COVID-19 and Related Developments
    7.13 Novavax
        7.13.1 Novavax Business Overview
        7.13.2 Novavax Influenza Vaccines Quarterly Production and Revenue, 2020
        7.13.3 Novavax Influenza Vaccines Product Introduction
        7.13.4 Novavax Response to COVID-19 and Related Developments
    7.14 Shijiazhuang Yiling Pharmaceutical
        7.14.1 Shijiazhuang Yiling Pharmaceutical Business Overview
        7.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Quarterly Production and Revenue, 2020
        7.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Introduction
        7.14.4 Shijiazhuang Yiling Pharmaceutical Response to COVID-19 and Related Developments
    7.15 SK Chemicals
        7.15.1 SK Chemicals Business Overview
        7.15.2 SK Chemicals Influenza Vaccines Quarterly Production and Revenue, 2020
        7.15.3 SK Chemicals Influenza Vaccines Product Introduction
        7.15.4 SK Chemicals Response to COVID-19 and Related Developments
    7.16 UNM Pharma
        7.16.1 UNM Pharma Business Overview
        7.16.2 UNM Pharma Influenza Vaccines Quarterly Production and Revenue, 2020
        7.16.3 UNM Pharma Influenza Vaccines Product Introduction
        7.16.4 UNM Pharma Response to COVID-19 and Related Developments
    7.17 Vaccitech
        7.17.1 Vaccitech Business Overview
        7.17.2 Vaccitech Influenza Vaccines Quarterly Production and Revenue, 2020
        7.17.3 Vaccitech Influenza Vaccines Product Introduction
        7.17.4 Vaccitech Response to COVID-19 and Related Developments
    7.18 Vaxart
        7.18.1 Vaxart Business Overview
        7.18.2 Vaxart Influenza Vaccines Quarterly Production and Revenue, 2020
        7.18.3 Vaxart Influenza Vaccines Product Introduction
        7.18.4 Vaxart Response to COVID-19 and Related Developments
    7.19 Vaxine Pty
        7.19.1 Vaxine Pty Business Overview
        7.19.2 Vaxine Pty Influenza Vaccines Quarterly Production and Revenue, 2020
        7.19.3 Vaxine Pty Influenza Vaccines Product Introduction
        7.19.4 Vaxine Pty Response to COVID-19 and Related Developments
    7.20 Visterra
        7.20.1 Visterra Business Overview
        7.20.2 Visterra Influenza Vaccines Quarterly Production and Revenue, 2020
        7.20.3 Visterra Influenza Vaccines Product Introduction
        7.20.4 Visterra Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
    8.1 Influenza Vaccines Supply Chain Analysis
        8.1.1 Influenza Vaccines Supply Chain Analysis
        8.1.2 Covid-19 Impact on Influenza Vaccines Supply Chain
    8.2 Distribution Channels Analysis
        8.2.1 Influenza Vaccines Distribution Channels
        8.2.2 Covid-19 Impact on Influenza Vaccines Distribution Channels
        8.2.3 Influenza Vaccines Distributors
    8.3 Influenza Vaccines Customers

9 Key Findings

10 Appendix
    10.1 About Us
    10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Influenza Vaccines Assessment Table 9. COVID-19 Impact: Influenza Vaccines Market Trends Table 10. COVID-19 Impact Global Influenza Vaccines Market Size Table 11. Global Influenza Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units) Table 12. Global Influenza Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit) Table 13. Global Influenza Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units) Table 14. Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units) Table 16. Global Influenza Vaccines Market Growth Drivers Table 17. Global Influenza Vaccines Market Restraints Table 18. Global Influenza Vaccines Market Opportunities Table 19. Global Influenza Vaccines Market Challenges Table 20. Key Manufacturers Influenza Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Influenza Vaccines Market Size, 2019 (K Units) & (US$ Million) Table 22. Influenza Vaccines Factory Price by Manufacturers 2020 (USD/Unit) Table 23. Location of Key Manufacturers Influenza Vaccines Manufacturing Plants Table 24. Key Manufacturers Influenza Vaccines Market Served Table 25. Date of Key Manufacturers Enter into Influenza Vaccines Market Table 26. Key Manufacturers Influenza Vaccines Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Influenza Vaccines Market Size by Type, 2020, (US$ Million) Table 29. Global Influenza Vaccines Market Size by Type, 2020 (K Units) Table 30. Global Influenza Vaccines Price: by Type, 2020-2021 (USD/Unit) Table 31. Global Influenza Vaccines Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Influenza Vaccines Market Size by Application, 2020-2021 (K Units) Table 33. Global Influenza Vaccines Price: by Application, 2020-2021 (USD/Unit) Table 34. Global Influenza Vaccines Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Influenza Vaccines Market Size by Region, 2019-2021 (K Units) Table 36. By Country, North America Influenza Vaccines Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Influenza Vaccines Market Size, 2019-2021 (K Units) Table 38. US Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 39. Canada Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Influenza Vaccines Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Influenza Vaccines Market Size, 2019-2021 (K Units) Table 43. Germany Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 44. France Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 45. UK Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 46. Italy Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Influenza Vaccines Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Influenza Vaccines Market Size, 2019-2021 (K Units) Table 50. China Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 51. Japan Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 52. South Korea Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 53. India Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 54. ASEAN Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 55. Latin America Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 56. Middle East and Africa Influenza Vaccines Market Size, 2019-2021 (US$ Million) & (K Units) Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. AstraZeneca Influenza Vaccines Product Table 60. AstraZeneca Response to COVID-19 and Related Developments Table 61. CSL Business Overview Table 62. CSL Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. CSL Influenza Vaccines Product Table 64. CSL Response to COVID-19 and Related Developments Table 65. GlaxoSmithKline Business Overview Table 66. GlaxoSmithKline Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. GlaxoSmithKline Influenza Vaccines Product Table 68. GlaxoSmithKline Response to COVID-19 and Related Developments Table 69. Sanofi Business Overview Table 70. Sanofi Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Sanofi Influenza Vaccines Product Table 72. Sanofi Response to COVID-19 and Related Developments Table 73. Altimmune Business Overview Table 74. Altimmune Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Altimmune Influenza Vaccines Product Table 76. Altimmune Response to COVID-19 and Related Developments Table 77. BionVax Business Overview Table 78. BionVax Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. BionVax Influenza Vaccines Product Table 80. BionVax Response to COVID-19 and Related Developments Table 81. FluGen Business Overview Table 82. FluGen Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. FluGen Influenza Vaccines Product Table 84. FluGen Response to COVID-19 and Related Developments Table 85. FOLIA BIOTECH Business Overview Table 86. FOLIA BIOTECH Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. FOLIA BIOTECH Influenza Vaccines Product Table 88. FOLIA BIOTECH Response to COVID-19 and Related Developments Table 89. Genentech Business Overview Table 90. Genentech Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Genentech Influenza Vaccines Product Table 92. Genentech Response to COVID-19 and Related Developments Table 93. Green Cross Business Overview Table 94. Green Cross Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Green Cross Influenza Vaccines Product Table 96. Green Cross Response to COVID-19 and Related Developments Table 97. Medicago Business Overview Table 98. Medicago Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Medicago Influenza Vaccines Product Table 100. Medicago Response to COVID-19 and Related Developments Table 101. Moderna Therapeutics Business Overview Table 102. Moderna Therapeutics Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Moderna Therapeutics Influenza Vaccines Product Table 104. Moderna Therapeutics Response to COVID-19 and Related Developments Table 105. Novavax Business Overview Table 106. Novavax Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Novavax Influenza Vaccines Product Table 108. Novavax Response to COVID-19 and Related Developments Table 109. Shijiazhuang Yiling Pharmaceutical Business Overview Table 110. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 111. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Table 112. Shijiazhuang Yiling Pharmaceutical Response to COVID-19 and Related Developments Table 113. SK Chemicals Business Overview Table 114. SK Chemicals Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 115. SK Chemicals Influenza Vaccines Product Table 116. SK Chemicals Response to COVID-19 and Related Developments Table 117. UNM Pharma Business Overview Table 118. UNM Pharma Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 119. UNM Pharma Influenza Vaccines Product Table 120. UNM Pharma Response to COVID-19 and Related Developments Table 121. Vaccitech Business Overview Table 122. Vaccitech Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 123. Vaccitech Influenza Vaccines Product Table 124. Vaccitech Response to COVID-19 and Related Developments Table 125. Vaxart Business Overview Table 126. Vaxart Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 127. Vaxart Influenza Vaccines Product Table 128. Vaxart Response to COVID-19 and Related Developments Table 129. Vaxine Pty Business Overview Table 130. Vaxine Pty Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 131. Vaxine Pty Influenza Vaccines Product Table 132. Vaxine Pty Response to COVID-19 and Related Developments Table 133. Visterra Business Overview Table 134. Visterra Influenza Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 135. Visterra Influenza Vaccines Product Table 136. Visterra Response to COVID-19 and Related Developments Table 137. Influenza Vaccines Distributors List Table 138. Influenza Vaccines Customers List Table 139. Covid-19 Impact on Influenza Vaccines Customers List of Figures Figure 1. Influenza Vaccines Product Picture Figure 2. Influenza Vaccines Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Influenza Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Influenza Vaccines Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Influenza Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Influenza Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Influenza Vaccines Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Influenza Vaccines Market Size Market Share, 2019-2021

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Fluorinating Reagents Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global Fluorinating Reagents Market Prior to COVID-19, the market for Fluorinating Reagents was anticipated to grow from US$ 43.26 million in 2020 to US$ 68.06 million by 2026; it is expected to grow at a CAGR of 7.85% d...

Global Electrostatic Sprayers Market Research Report 2020

Market Analysis and Insights: Global Electrostatic Sprayers Market The global Electrostatic Sprayers market was valued at US$ 16.05 million in 2020 and it is expected to reach US$ 59.52 million by the end of 2027, growing at a CAGR of -3.35% during 2...

Global Caviar Market Insights, Forecast to 2027

Market Analysis and Insights: Global Caviar Market In 2019, the global Caviar market size was increased to US$ 356.2 million, and it will reach US$ 531.45 million in 2027, growing at CAGR of 8.26% between 2020 and 2027. Global Caviar Scope and Segmen...

Global 3C Coating Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global 3C Coating Market In 2019, the global 3C coating market size was 1174.00 million USD and it is expected to reach 1147.76 million USD by the end of 2026, with a CAGR of 1.97% between 2020 and 2026. Global 3C Coatin...

COVID-19 Impact on Slim Cigarette Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Slim Cigarette, including the following market information: Global Slim Cigarette Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) a (Billin Sticks) Global Slim Cigarette Marke...

Publisher: QY Research